Back to Journals » Cancer Management and Research » Volume 5

Long-term use of dasatinib in patients with metastatic castration-resistant prostate cancer after receiving the combination of dasatinib and docetaxel

Total article views   HTML views PDF downloads Totals
10,722 Dovepress* 9,087+ 1,637 10,724
PubMed Central* 1,635 214 1,849
Totals 10,722 1,851 12,573
*Since 9 March 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 1 0 0 0 1

View citations on PubMed Central and Google Scholar